COVID‐19 is a novel, rapidly changing pandemic: consequently, evidence‐based
recommendations in solid organ transplantation (SOT) remain challenging and unclear. To …

Engineered T cell receptor T (TCR-T) cell therapy has facilitated the generation of
increasingly reliable tumor antigen-specific adaptable cellular products for the treatment of …

With implementation of the Kidney Allocation System, the growth of kidney paired donation
programs, and advances in desensitization and immunosuppression, the outlook for …

In March 2020, coronavirus disease 2019 (COVID-19) spread rapidly nationally, causing
widespread emergent changes to the health system. Our goal was to understand the impact …

Molecular docking is a standard computational approach to predict binding modes of protein–
ligand complexes by exploring alternative orientations and conformations of the ligand (ie …

The impact of donor quality on post–kidney transplant (KT) survival may vary by candidate
condition. Characterizing this variation would increase access to KT without sacrificing …

Deceased donor kidney transplantation (DDKT) rates for highly sensitized (HS) candidates
increased early after implementation of the Kidney Allocation System (KAS) in 2014 …

Background Neoantigen (NeoAg) peptides displayed at the tumor cell surface by human
leukocyte antigen molecules show exquisite tumor specificity and can elicit T cell mediated …

Background Pre–liver transplant (LT) sarcopenia is associated with poor survival. Methods
exist for measuring body composition with use of CT scans; however, it is unclear which …

COVID‐19 has profoundly affected the American health care system; its effect on the liver
transplant (LT) waitlist based on COVID‐19 incidence has not been characterized. Using …